SH

Scott Hammer

Credentials: · ·

History

Infectious Disease
1975–1977
Internal Medicine
1972–1975
Doctor of Medicine
1968–1972

Research

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS…
New England Journal of Medicine · 1997 · First of 12 authors · 2,257 citations
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel
Review · JAMA · 2000 · 895 citations
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
JAMA · 2008 · First of 16 authors · Corresponding · 768 citations

DK
David Katzenstein
29 papers
MH
Martin Hirsch
24 papers
Magdalena Sobieszczyk
21 papers
Margaret Fischl
21 papers
DR
Douglas Richman
20 papers
JM
John Mellors
16 papers
Juliana McElrath
13 papers
LD
Lisa Demeter
13 papers
Michael Saag
13 papers
MT
Melanie Thompson
12 papers
Robert Schooley
12 papers
Joseph Eron
11 papers

Grants

Columbia Integrated Training Program in Infectious Diseases Research
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $1.1M · Columbia University Health Sciences
2013–2023
HIV Vaccines Clinical Trials Network Leadership and Operations Center
National Institute of Allergy and Infectious Diseases · UM1
PI · $267.1M · Fred Hutchinson Cancer Center
2006–2020
Columbia Collaborative HIV/AIDS Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $14.5M · Columbia University Health Sciences
2007–2020
Enhancing, Training, Research Capacity and Expertise in Hiv Care-Entree
Fogarty International Center · R24
PI · $8.6M · University of Kwazulu-Natal
2010–2017

Clinical trials

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
Study chair · Terminated · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2009–2017
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Study chair · Completed
HIV Vaccine Trials Network
2002–2009
Adding New Drugs for HIV Infected Patients Failing Current Therapy
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2004
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Study chair · Withdrawn · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)